Nevil Chimon, MBA PhD 18+ years in pharma drug discovery, manufacturing and healthcare operations and management roles. Creating a strategy and executing plans that build teams, capabilities and revenue whilst managing uncertainty. Transforming progress, productivity and operating expenses through Lean-six-sigma. Entrepreneurial mindset, continuously identifying and developing business opportunities across geographies. As a leader in drug discovery and diagnostic healthcare over the last two decades, Nevil has helped transform how drugs are tested and changed the direction of clinical trial design by using molecular imaging to save tens of millions of dollars for Big Pharma.
In 2010, as CEO, he helped grow the largest private diagnostic clinic in Singapore with unmatched capabilities in nuclear medicine, successfully completing M&As with Fortis Healthcare in 2012 for USD56M and Fullerton Healthcare in 2014 for USD85M. Nevil’s technical expertise and entrepreneurial focus has helped raise capital for several start-ups. Supporting VCs to evaluate disruptive technologies using AI to accelerate disease diagnosis and drug discovery.